Evaluation of the cell death pathway and apoptosis-stunning effect relationship after low- and high-dose I-131 administrations in rat thyroid tissue

Cancer Biotherapy and Radiopharmaceuticals

Volumn 21, Issue 4, 2006, Pages 342-351

  Turgut, Bulent ^a   Babul, Aydan ^b   Ozdemir, Ozturk ^a   Erselcan, Taner ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Iodine 131; Necrosis; Rat; Stunning; Thyroid

Indexed keywords

IODINE 131;

ADOLESCENT; AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; EVALUATION; LOW ENERGY RADIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RAT; SCINTILLATION CAMERA; THYROID GLAND;

ANIMALS; APOPTOSIS; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; IODINE RADIOISOTOPES; MALE; RATS; RATS, WISTAR; THYROID GLAND;

EID: 33750627644     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2006.21.342     Document Type: Article

References (29)

1. Vatulina GG, Tuzhilkova TN, Goloshchapova ZhA. Postradiation changes in the thyroid gland and skeletal muscle after exposure to iodine-131. Radiobiologiia 1986;26:499.
2. Guiraud-Vitaux F, Feldmann G, Vadrod N, et al. Early ultrastructural injuries in the thyroid of the normal rat radioinduced by diagnostic and/or therapeutic amounts of iodine-131. Cell Mol Biol (Noisy-le-grand) 2001;47:495.
3. Swiatecka J, Dzieciol J, Anchim T, et al. Influence of estrogen, antiestrogen, and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture. Neoplasma 2000;47:15.
4. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995;33:781.
5. Peltenburg LTC. Radiosensitivity of tumor cells. Oncogenes and apoptosis. Q J Nucl Med 2000;44:355.
6. Brenner W. Is thyroid stunning a real phenomenon or just fiction? J Nucl Med 2002;43:835.
7. Postgard P, Himmelman J, Lindencrona U, et al. Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells). J Nucl Med 2002;43:828.
8. Sabri O, Zimny M, Schreckenberger M, et al. Does thyroid stunning exist? A model with benign thyroid disease. Eur J Nucl Med 2000;27:1591.
9. Takahashi S, Thuy DT, Sato H, et al. Effects of the restriction of food and water intake on the distribution and retention of radioiodine in mice. J Radiat Res (Tokyo) 2000;41:313.
10. Ozdemir O, Bulut HE, Korkmaz M, et al. Increased cell proliferation and R.Msp1 fragmentation induced by 5-aza-2′-deoxycytidine in rat testes related to the gene-imprinting mechanism. Exp Toxicol Pathol 2000;52:317.
11. Cooper GM, ed. Fundamentals of molecular biology. The cell, a molecular approach. Recombinant DNA. Washington DC: ASM Press, 1997;104.
12. Tanimoto C, Hirakawa S, Kawasaki H, et al. Apoptosis in thyroid diseases: A histochemical study. Endocr J 1995;42:193.
13. Bagchi N, Brown TR, Sundick RS. Thyroid cell injury is an initial event in the induction of autoimmune thyroiditis by iodine in obese strain chickens. Endocrinology 1995;136:5054.
14. Many MC, Maniratunga S, Varis I, et al. Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone nonobese diabetic mice: Effects of iodine-induced cell necrosis. J Endocrinol 1995;147:311.
15. Contempre B, Dumont JE, Denef JF, et al. Effects of selenium deficiency on thyroid necrosis, fibrosis, and proliferation: A possible role in myxoedematous cretinism. Eur J Endocrinol 1995;133:99.
16. Kotani T, Aratake Y, Hirai K, et al. Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 1995;20:231.
17. Tamura M, Kimura H, Koji T, et al. Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system. Endocrinology 1998;139:3646.
18. Reynolds JC, Robbins J. The changing role of radioiodine in the management of differentiated thyroid cancer. Semin Nucl Med 1997;27:152.
19. 131I- induced changes in thyroid function. J Endocrinol Invest 1986;9:367.
20. Hanauer G. Estimate of the dosage for radioiodine ablation of the thyroid gland in male Wistar rats. Zentralbl Veterinarmed A 1990;37:747.
21. 131I-scanned and nonscanned individuals. J Clin Endocrinol Metab 2001;86:3507.
22. Morris LF, Waxman AD, Braunstein GD. Thyroid stunning. Thyroid 2003;13:333.
23. Bajen MT, Salvador M, Munoz A, et al. Effect of a diagnostic dose of 185 MBq 131-I on postsurgical thyroid remnants. J Nucl Med 2000;41:2038.
24. 131I-scanning: Avoidance of negative therapeutic uptake due to stunning. Clin Endocrinol (Oxf) 2001;55:515.
25. Dam HQ, Kim SM, Lin HC, et al. 131-I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning. Radiology 2004;232:527.
26. Park HM, Park YH, Zhou XH. Detection of thyroid remnant/metastasis without stunning: Ongoing dilemma-the diagnostic accuracy of 123-I and 131-I as scanning agents and their effect on the outcome of radioablation therapy. Thyroid 1997;7:277.
27. Muratet JP, Daver A, Minier JF, et al. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med 1998;39:1546.
28. DelTerra E, Francesconi A, Meli A, et al. Radiation-dependent apoptosis on cultured thyroid cells. Phys Med 2001;17(Suppl 1):261.
29. Zheng R, Dahlstrom KR, Wei Q, et al. Gamma radiation-induced apoptosis, G2 delay, and the risk of salivary and thyroid carcinomas-a preliminary report. Head Neck 2004;26:612.